Triatomic Management LP - Q1 2023 holdings

$149 Million is the total value of Triatomic Management LP's 55 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 100.0% .

 Value Shares↓ Weighting
WISH ExitCONTEXTLOGIC INC$0-100,000
-100.0%
-0.04%
LUMN ExitLUMEN TECHNOLOGIES INC$0-25,200
-100.0%
-0.11%
TSLA ExitTESLA INC$0-2,000
-100.0%
-0.21%
INO ExitINOVIO PHARMACEUTICALS INC$0-235,000
-100.0%
-0.31%
ExitLUCID GROUP INC$0-55,000
-100.0%
-0.32%
TDOC ExitTELADOC HEALTH INC$0-17,000
-100.0%
-0.34%
BYND ExitBEYOND MEAT INC$0-40,242
-100.0%
-0.42%
MU ExitMICRON TECHNOLOGY INC$0-10,000
-100.0%
-0.42%
ZLAB ExitZAI LAB LTDadr$0-17,710
-100.0%
-0.46%
GOTU ExitGAOTU TECHEDU INCsponsored ads$0-234,590
-100.0%
-0.47%
MSTR ExitMICROSTRATEGY INCput$0-16,500
-100.0%
-1.96%
XLI ExitSELECT SECTOR SPDR TRput$0-50,000
-100.0%
-4.13%
AMZN ExitAMAZON COM INCcall$0-70,000
-100.0%
-4.95%
XLF ExitSELECT SECTOR SPDR TRput$0-200,000
-100.0%
-5.76%
SPY ExitSPDR S&P 500 ETF TRcall$0-20,000
-100.0%
-6.44%
DIA ExitSPDR DOW JONES INDL AVERAGEput$0-40,000
-100.0%
-11.15%
XBI ExitSPDR SER TRcall$0-300,000
-100.0%
-20.95%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-03
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CAREMAX INC8Q3 20235.5%
INSULET CORP8Q3 20237.3%
ADAPTIVE BIOTECHNOLOGIES COR8Q3 20233.3%
THE ONCOLOGY INSTITUTE INC8Q3 20232.5%
SAMSARA INC8Q3 20232.3%
DERMTECH INC8Q3 20232.5%
SINGULAR GENOMICS SYSTEMS IN8Q3 20233.5%
NANO X IMAGING LTD8Q3 20230.2%
INVIVYD INC8Q3 20230.1%
CAREMAX INC8Q3 20230.1%

View Triatomic Management LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-03
13F-HR/A2023-09-07
13F-HR2023-08-14
13F-HR2023-05-03
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-12
13F-HR2022-02-14

View Triatomic Management LP's complete filings history.

Export Triatomic Management LP's holdings